Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

BRII-B

1.810
-0.030-1.63%
Volume:1.62M
Turnover:2.90M
Market Cap:1.30B
PE:-2.38
High:1.830
Open:1.820
Low:1.760
Close:1.840
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
BRII-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
98
Office Location:
Building 7, International Science Park,3rd Floor, Zhongguancun Dongsheng,No. 1 North Yongtaizhuang Road,Haidian District,Beijing,China
Website:
http://www.briibio.com
Zip Code:
100192
Phone:
- -
Fax:
- -
Introduction:
Brii Biosciences Ltd is a biotechnology company principally focused on developing therapies for infectious diseases and central nervous system diseases. The Company's HBV portfolio products include the proprietary therapeutic vaccine BRII-179, the siRNA BRII-835 (elebsiran), and the neutralizing antibody BRII-877 (tobevibart). The Company owns a broad pipeline of multiple innovative drug candidates that focus on infectious diseases and central nervous system diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The Company mainly conducts its businesses in China market.

Directors

Name
Position
Zhi Hong
Chairman of the Board,Executive Director,Member of the Nomination Committee
LI An Kang
Executive Director,Chairman of the Strategic and Development Committee
Grace Hui TANG
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit and Risk Management Committee Chairman
TSUI Yiu Wa Alec
Independent Director,Member of the Remuneration and Assessment Committee,Audit and Risk Management Committee Member
Gregg H. Alton
Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee
Martin J Murphy JR
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
YANG Tai Ying
Independent Director,Member of the Strategic and Development Committee,Audit and Risk Management Committee Chairman

Shareholders

Name
Position
Zhi Hong
CEO
Eleanor (Ellee) de Groot
Vice General Manager,CTO
Aleksandar Skuban
Vice General Manager,Other Senior Executives
LIANG Xu
Vice General Manager,Other Senior Executives
LI An Kang
CFO,Corporate Secretary
HE Yong Zi
Corporate Secretary
Brian Alvin Johns
Chief Science Officer
XU Lian Hong
Other Senior Executives
ZHU Qing
Other Senior Executives,Other Senior Executives
Jean-Luc Samuel Francois GIRARDET
Other Senior Executives
Lisa Trivison BECK
Other Senior Executives
David Margolis
Other Senior Executives,Other Senior Executives
Karen D. Neuendorff
Other Senior Executives
Susannah Cantrell
Other Senior Executives